ResApp re- enters
TECH health company ResApp, which holds the exclusive licence to develop an inventive telehealth app based on technology funded by Bill and Melinda Gates, has enjoyed a solid re- entry to the Australian sharemarket. ResApp shares began trading at 2.3c at 10am yesterday after undertaking an oversubscribed public capital raising of $ 4 million. They closed at 2.2c, a rise of 10 per cent on the 2c issue price. The company was re- listed after being acquired by Narhex Life Sciences in February.